Medidata Nearly Doubles Usage of Its Clinical Trial Management System in Year since Acquisition

New Seamless Integration with Medidata’s Cloud-based EDC/CDMS Driving Strong Momentum in New Customer Commitments

NEW YORK--(BUSINESS WIRE)--During the first year of offering Medidata CTMS™, an innovative cloud-based clinical trial management system, Medidata Solutions (NASDAQ: MDSO) dramatically expanded its CTMS customer base and is launching a major product enhancement—a seamless integration of Medidata CTMS with Medidata Rave^®, a leading electronic data capture (EDC) and clinical data management system (CDMS).

“Medidata CTMS fulfills our customers’ need for an innovative, scalable solution that brings the same type of efficiencies to clinical operations as the rest of the Medidata Clinical Cloud”

With the integration, Medidata offers customers a single, out-of-the-box solution for EDC, CDM and CTM that can streamline their clinical operations in an easy-to-deploy, cloud-based platform. The CTMS was acquired by Medidata through its acquisition of Clinical Force in July 2011, and since then the number of active studies running on the platform has grown by more than 85 percent.

“Medidata CTMS fulfills our customers’ need for an innovative, scalable solution that brings the same type of efficiencies to clinical operations as the rest of the Medidata Clinical Cloud,” said Glen de Vries, president, Medidata Solutions. “Given that we continue to enhance Medidata CTMS’ functionality—most recently releasing an upgrade that seamlessly integrates with Medidata Rave—it is no surprise that the number of studies actively running on the platform has nearly doubled over the past year.”

The integration between Medidata CTMS and Rave increases the efficiency of study monitors and clinical research associates. Data is automatically pulled from Rave into Medidata CTMS monitor reports, limiting room for errors and cutting out redundancies in data entry, contributing to time savings and improved data quality. With an increase in the number of study monitors actively using the system today—in fact, 60 percent more compared to just one year ago—the new out-of-the-box integration translates into significant aggregate time savings for life science companies.

To support increased customer usage of this enhanced product, Medidata now offers its customers an eLearning course, Medidata CTMS for Monitors, which provides instruction on best practices for site monitoring tasks, as part of the Medidata University product training program.

Connect with Medidata:

• Read our blog, Geeks Talk Clinical
• Tweet this: .@Medidata celebrates 85% growth in #CTMS usage in its first year, now offered with #MedidataRave EDC integration http://bit.ly/PLELj3
• Follow us on Twitter: @Medidata
• Find us on LinkedIn

About Medidata Solutions Worldwide

Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.